Medline MDLN

Medline initiates field action for beds

Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Routine
  1. Voluntary field action for Medline Brand beds
  2. Net sales of affected products: $60 million
  3. Estimated costs up to $220 million
  4. Expected to be excluded from Adjusted EBITDA

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when Medline files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.